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Abstract: Background: Psoriasis	 is	 a	 chronic	 and	prevalent	disease,	 and	 the	associated	pruritus	 is	 a	 common,	difficult-to-
control symptom. The mediators involved in psoriatic pruritus have not been fully established. 
oBjective: To evaluate associations between the number of mast cells in psoriatic lesions and the intensity of pruritus. 
Methods: 29	patients	with	plaque	psoriasis	were	recruited.	In	all	participants,	Psoriasis	Area	and	Severity	Index	and	Body	
Surface	Area	 were	 assessed.	A	 questionnaire	 was	 administered	 to	 obtain	 clinical	 information	 and	 the	 Dermatology	 Life	
Quality	Index.	Pruritus	was	assessed	using	a	visual	analog	scale	and	skin	biopsies	were	performed	for	staining	with	Giemsa	
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is	seen	in	70%	to	90%	of	patients	with	psoriasis.3-6 Despite being a 
very	frequent	symptom,	pathophysiology	of	pruritus	in	psoriasis	it	
is not yet understood.7 Many studies demonstrate increased expres-
sion	of	substance	P	in	psoriasis	plaques,	being	this	substance	also	




the increase in number and the early activation of cutaneous mast 
cells	 typical	findings	of	psoriatic	 inflammation.9-13 One of the ear-
ly morphological changes observed is mast cell degranulation.14,15 
In	active	lesions	and	in	nonaffected	skin	of	patients	with	psoriasis,	
mast cell degranulation is associated to vascular changes and angio-
genesis.14,16 Both phenomena are vitally important in the pathophys-
iology of psoriasis.17
Cutaneous	 innervation	 is	 increased	 in	 the	 skin	with	 pso-
riasis	 and	 pruritus	 compared	 to	 the	 skin	with	 no	 pruritus.18 The 
increased innervation can worsen the intensity of the symptom in 
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psoriasis	patients	with	inflammation,19 what can explain the higher 
incidence of pruritus in the phases when the disease is more active. 
Changes in dermal vasculature secondary to the release of hista-
mine	by	mast	cells,	in	psoriasis	lesions	can	maybe	have	an	import-
ant role in the pathophysiology of pruritus in psoriasis.7
The	majority	of	patients	incriminates	stress	as	a	triggering	factor	for	
both psoriasis lesions and the pruritus associated to the condition.3,18 





can lead to mast cell degranulation.20,21 
There	are	few	studies	regarding	the	quantification	of	mast	
cells in psoriasis lesions. This is one of the few studies that propos-
es to evaluate the relationship between the amount of mast cells in 
psoriasis lesions with the intensity of the pruritus. 
METHODS
It	 is	 a	 cross-sectional	 study	design,	 conducted	 from	April	
to	December	2013.	During	 this	period,	patients	18	years	of	age	or	
older,	with	psoriasis	vulgaris	who	were	patients	at	the	ambulatory	
of psoriasis of the service of dermatology at Hospital de Clínicas de 
Porto	Alegre	were	invited	to	participate	in	the	study.	The	sampling	
was	 performed	 by	 convenience,	with	 29	 patients	 included	 in	 the	
study after the eligibility criteria. Were considered exclusion crite-
ria:	patients	taking	medications	that	induce	mast	cell	degranulation,	
pregnancy and patients being treated with phototherapy.
The research was approved by the ethics committee in re-
search of the Universidade Federal do Rio Grande do Sul under the 
protocol	number	13-0128.	All	patients	included	in	the	study	signed	
an informed consent form.
Patients	 filled	 out	 questionnaires:	 one	 for	 the	 evaluation	
of	the	clinical	and	epidemiological	characteristics	such	as	sex,	age,	






After	 clinical	 evaluation,	 the	 patient	 underwent	 a	 4mm	
punch	skin	biopsy	in	an	area	with	an	active	lesion	of	psoriasis.	Skin	
samples	were	 fixated	 in	 formalin,	 embedded	 into	 paraffin	 blocks	
and	 stained	with	GIEMSA	 and	C-Kit	 (CD-117).	Mast	 cell	 density	
was	analyzed	by	a	single	pathologist	on	the	optical	microscopy	with	
a	40x	power.	At	least	three	fields	were	examined	and	the	main	num-
ber of mast cells calculated for each of the two staining methods.






compared by the Mann-Whitney test and the categorical by the 
Fisher’s	exact	test.	The	concordance	between	the	staining	methods	





Clinical and epidemiological characteristics
Of	 the	 29	 patients	 participating	 in	 the	 study,	 44.8%	were	
male	and	55.2%	female,	with	a	mean	age	of	50	years.	Of	those,	89.7%	





(MTX),	 6.9%	 acitretin,	 58.6%	 topical	 steroids	 and	 17.2%	 formula-
tions	with	liquor	carbonis	detergens	(LCD)	and	salicylic	acid	(SA).






with	daily	 symptoms.	Most	 (82.8%)	complained	of	 the	 symptoms	
only	in	the	psoriasis	lesions	while	17.2%	complained	of	diffuse	pru-

















table 1: Description of the maximum and minimum values, 
median and interquartile interval of the variables PASI, BSA, 
DLQI, VAS
Minimum Maximum Median Percentiles 
(25-75)
PASI 1.8 29.30 7.6 5.35-25.05
BSA 1 76 17 10-29.5
DLQI 0 26 5 2.5-12.5
VAS 0 10 6 2-8














In	 table	 2,	 we	 compared	 the	 density	 of	mast	 cells	 (mean	
variable	for	both	stains	–	IHC	and	GIEMSA)	in	patients	who	were	
using	some	treatment	for	psoriasis	(topical	or	systemic)	and	those	
who	were	not	using	 any	 treatment	 at	 the	 time	of	 the	 study,	with	
no	 statistically	 significant	 difference	 between	 those.	 Even	 though	
patients using mast cell degranulating drugs were excluded from 
the	study,	the	use	of	drugs	for	the	treatment	of	psoriasis	could	have	
altered	the	mast	cell	count	in	the	lesions	of	psoriasis,	as	well	as	the	




between	 -1.49	and	10.83.	C-Kit	 staining	 identifies	more	mast	 cells	







of mast cells in the dermis.
DISCUSSION
Psoriasis	 is	a	 chronic,	 stigmatizing	dermatological	disease	




of life of those affected.23









cy as a function of the measurement
Data	presented	by	mean	±	standard	deviation	and	compared	by	Student’s	t	test	for	
independent samples.
table 2: Quantification of mast cells in biopsies of psoriasis 
patients and pruritus who use medication or not, stained by 
different techniques
With psoriasis 
treatment n = 19
Without psoriasis 
treatment n = 10
P
GIEMSA 6.8	±	3.0 6.4	±	1.6 0.757
IHC 12.0	±	5.2 10.0	±	2.3 0.152
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Our	results	confirm	data	in	the	literature	that	demonstrate	








For	 the	 adequate	management	 of	 pruritus	 in	 psoriasis,	 it	
is	necessary	 to	understand	 its	pathophysiology.	Nakamura	 et al.19 
were	the	first	to	document	the	local	market	is	associated	to	pruri-






the authors observed the large amount of degranulating mast cells 
in	 the	papillary	dermis	of	patients	with	pruritus.	However,	 in	 the	
above-mentioned	 study,	 the	 patients	 discontinued	 their	 psoriasis	
topical	treatments	two	weeks	before	starting	the	study,	and	the	sys-
temic	treatments	three	months	before.	In	our	study,	both	topical	and	
systemic	 treatment	 for	 psoriasis	 were	maintained,	 representing	 a	
possible	limitation,	because	it	is	known	that	the	use	of	topical	ste-
roids and some systemic medications such as retinoids in cyclospo-
rine can reduce the mast cell count.26 
The	major	limitation	of	our	study	was	the	small	sample	size,	
with an estimated calculation in order to detect a moderate correla-
tion	with	a	value	of	r≥	0.5,	considering	a	strength	of	80%	and	the	
significance	level	of	0.05.	However,	it	is	also	important	to	note	that	
we did not consider the time of the lesions or the biopsy site (if in 
a	photoexposed	area	or	not)	 in	our	results.	These	data	could	alter	
our	results,	since	a	higher	density	of	mast	cells	can	be	seen	in	recent	
lesions of psoriasis and in photoexposed areas since mast cells are 
activated	and	recruited	by	ultraviolet	and	infrared	radiation,	as	well	
as by heat.	9,27 
Toruniowa	e	 Jablónska9 studied 122 patients with psoriasis 





reinforcing the involvement of mast cells in early psoriasis lesions.
Multiple mediators have been associated to pruritus in pso-
riasis,	but	none	was	in	fact	proven	as	cause	of	pruritus.	Histamine,	
which is one of the main pruritus mediators in many dermatologi-
cal	conditions,	seems	not	to	be	involved	in	the	symptom	of	patients	
with	psoriasis.	A	correlation	between	 the	 intensity	of	 the	pruritus	




Many studies already demonstrated the abnormal expres-
sion and/or distribution of many neuropeptides and their recep-
tors	 in	 psoriasis	 lesions,	 among	 those	 substance	 P	 (SP)	 calcitonin	
gene-related	 peptide	 (CGRP)	 and	 vasoactive	 intestinal	 peptide	
(VIP).	Besides,	many	cytokines,	in	particular	IL-2	have	also	been	im-
plicated in the pathophysiology of pruritus in psoriasis.19	However,	
there	are	still	many	gaps,	such	as	the	exact	role	of	the	central	ner-
vous	system	in	chronic	pruritus.	Therefore,	more	studies	are	needed	





the pathophysiology of pruritus in psoriasis is complex and mul-
tifactorial. We also conclude that the estimated mast cell count is 
more	precise	with	the	technique	of	IHC	compared	to	GIEMSA,	espe-
cially when a large number of mast cells is considered. Future stud-
ies	are	needed,	evaluating	the	pruritus	mediators	and	considering	
other	variables,	such	as	 time	of	 the	 lesions	and	areas	biopsied	for	
better understanding of pruritus in psoriasis. q
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